CME CME Group Inc - Class A

  1. Stocks
  2. Financial Services
  3. NASDAQ: CME

Price (delayed)

$305.71

Market cap

$109.93B

P/E Ratio

25.73

Dividend/share

$11.3

EPS

$11.88

Enterprise value

$269.32B

?
Relative Growth: Rel. Growth: 64
Relative Strength: Rel. Strength: 73
Relative Valuation: Rel. Valuation: 26
Relative Profitability: Rel. Profitability: 91

As the world's leading derivatives marketplace, CME Group ( www.cmegroup.com ) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants ...

Highlights
The EPS is up by 15% year-on-year
The company's net income rose by 14% YoY
The debt has grown by 11% year-on-year but it has declined by 4.1% since the previous quarter
CME's P/E is 9% above its last 4 quarters average of 23.6 and 4.3% above its 5-year quarterly average of 24.7
The equity has declined by 4.4% year-on-year
Sector: Financial Services
Industry: Financial Data & Stock Exchanges
Website: http://www.cmegroup.com
Peers: MSCI ICE CBOE NDAQ

Key stats

What are the main financial stats of CME

CME stock price

How has the CME Group stock price performed over time
Intraday
-0.09%
1 week
4.03%
1 month
12.89%
1 year
13.69%
YTD
11.95%
QTD
16.69%

Financial performance

How have CME Group's revenue and profit performed over time
Revenue
$6.77B
Gross profit
$6.77B
Operating income
$4.41B
Net income
$4.26B
Gross margin
100%
Net margin
62.9%
The company's net income rose by 14% YoY
The net margin has grown by 8% year-on-year
The operating income is up by 4.8% YoY
The gross profit has increased by 5% YoY

Price vs fundamentals

How does CME's price correlate with its fundamentals

Growth

What is CME Group's growth rate over time

Valuation

What is CME Group stock price valuation
CME P/E details
P/E
25.73
P/B
4.18
P/S
16.28
EV/EBIT
46.9
EV/EBITDA
44.33
EV/Sales
39.77
The EPS is up by 15% year-on-year
CME's P/E is 9% above its last 4 quarters average of 23.6 and 4.3% above its 5-year quarterly average of 24.7
CME's price to book (P/B) is 44% higher than its 5-year quarterly average of 2.9 and 19% higher than its last 4 quarters average of 3.5
The equity has declined by 4.4% year-on-year
The P/S is 15% higher than the 5-year quarterly average of 14.2 and 13% higher than the last 4 quarters average of 14.4
CME's revenue is up by 5% year-on-year

Efficiency

How efficient is CME Group business performance
The ROIC has contracted by 15% YoY and by 2.8% from the previous quarter
CME Group's return on equity has increased by 13% YoY
The return on sales is up by 9% year-on-year
CME Group's return on assets has decreased by 8% YoY

Dividends

What is CME's dividend history
Dividend details
DPS
$11.3
Dividend yield
3.7%
Payout ratio
95.1%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did CME Group financials performed over time
CME Group's total assets is 16% more than its total liabilities
CME Group's total liabilities has increased by 11% YoY but it has decreased by 4.1% QoQ
CME Group's total assets has increased by 8% YoY but it has decreased by 3.6% from the previous quarter
The debt to equity has grown by 16% YoY but it has contracted by 3.8% from the previous quarter
The debt has grown by 11% year-on-year but it has declined by 4.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.